Skip to main content
. 2017 Oct 6:217–229. doi: 10.1016/B978-0-12-802761-5.00011-0

Figure 11.3.

Figure 11.3

Invasive adenocarcinoma of prostate.

(A) Hematoxylin and eosin (H&E) of invasive adenocarcinoma of prostate. By H&E alone, the differential diagnosis includes invasive adenocarcinoma and adenosis. (B) High-molecular-weight cytokeratin immunostain of invasive adenocarcinoma of prostate. Loss of high-molecular-weight cytokeratin (34βE12) immunoreactivity around the glands of interest supports a diagnosis of invasive adenocarcinoma.